PDEX vs VRTX · P/E 16, rev $66.6M vs P/E 30, rev $12.00B
Pro-Dex Inc (PDEX) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Pro-Dex Inc (PDEX) is a medical instruments & supplies company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported PDEX revenue for 2025-06-30 was $66.6M. Net income was $155.0K. Revenue was up 23.7% from 2024-06-30 to 2025-06-30. PDEX currently screens at market cap $146.4M and trailing P/E 16.3.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
PDEX currently screens at market cap $146.4M and trailing P/E 16.3. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the PDEX and VRTX stock pages for the full models.
Not investment advice.